| Literature DB >> 25807300 |
Melissa D'Ascenzio1, Paola Chimenti1, Maria Concetta Gidaro2, Celeste De Monte1, Daniela De Vita1, Arianna Granese1, Luigi Scipione1, Roberto Di Santo1, Giosuè Costa2, Stefano Alcaro2, Matilde Yáñez3, Simone Carradori4.
Abstract
Several (thiazol-2-yl)hydrazone derivatives from 2-, 3- and 4-acetylpyridine were synthesized and tested against human monoamine oxidase (hMAO) A and B enzymes. Most of them had an inhibitory effect in the low micromolar/high nanomolar range, being derivatives of 4-acetylpyridine selective hMAO-B inhibitors also at low nanomolar concentrations. The structure-activity relationship, as confirmed by molecular modeling studies, proved that the pyridine ring linked to the hydrazonic nitrogen and the substituted aryl moiety at C4 of the thiazole conferred the inhibitory effects on hMAO enzymes. Successively, the strongest hMAO-B inhibitors were tested toward acetylcholinesterase (AChE) and the most interesting compound showed activity in the low micromolar range. Our results suggest that this scaffold could be further investigated for its potential multi-targeted role in the discovery of new drugs against the neurodegenerative diseases.Entities:
Keywords: (thiazol-2-yl)hydrazone derivatives; AChE inhibitors; Acetylpyridine; hMAO inhibitors; molecular modeling; neurodegenerative diseases
Mesh:
Substances:
Year: 2015 PMID: 25807300 DOI: 10.3109/14756366.2014.987138
Source DB: PubMed Journal: J Enzyme Inhib Med Chem ISSN: 1475-6366 Impact factor: 5.051